Top 10 VC medical device deals H2 2011

There has been a lot of talk in biopharma circles about the decline of venture capital funding. But as we can see from this report in FierceMedicalDevices, there are medtech companies raking in cash. What are the hot companies receiving top backing? We look at the top 10 deals from the second half of 2011. Report

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.